FOCUS: A Phase I/II First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMD
Clinical trial NCT03846193 · TERMINATED
Trial details
- NCT number
- NCT03846193
- Sponsor
- Gyroscope Therapeutics Limited
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-17
- Primary completion
- 2024-06-25
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.